NATCO PHARMA LTD. - 524816 - Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended 31St March, 2024
Audited Financial Results for the quarter and year ended 31st March, 202427-05-2024
27-05-2024
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investor Meet24-05-2024
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investor Meet24-05-2024
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of Confirmation22-05-2024
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of letter of confirmation for duplicate share certificate16-05-2024
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company will host an Earnings Call with Investors / Analysts on Tuesday, the May 28, 2024 at 11:00 AM IST to disseminate Financial Results of the Company for the quarter and year ended on March 31, 2024.15-05-2024
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate14-05-2024
NATCO PHARMA LTD. - 524816 - Board Meeting Intimation for Approval Of The Audited Financial Results For The Quarter And Year Ended March 31, 2024
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 ,inter alia, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 202409-05-2024
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Duplicate Share certificate/letter of confirmation06-05-2024
NATCO PHARMA LTD. - 524816 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate02-05-2024